ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

NCT05434156 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Major Depressive Disorder
Depression

Interventions

DRUG: ELE-101
DRUG: ELE-101 Placebo

Sponsor

Eleusis Therapeutics

Collaborators

[object Object]